Form 8-K - Current report:
SEC Accession No. 0001193125-25-142039
Filing Date
2025-06-17
Accepted
2025-06-17 16:02:19
Documents
13
Period of Report
2025-06-13
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d936533d8k.htm   iXBRL 8-K 51746
2 EX-3.1 d936533dex31.htm EX-3.1 7024
  Complete submission text file 0001193125-25-142039.txt   177922

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qttb-20250613.xsd EX-101.SCH 2847
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qttb-20250613_lab.xml EX-101.LAB 17980
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qttb-20250613_pre.xml EX-101.PRE 11256
16 EXTRACTED XBRL INSTANCE DOCUMENT d936533d8k_htm.xml XML 3729
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Filer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38433 | Film No.: 251053264
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)